GFM
IRWD icon

GF Fund Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

GF Fund Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.8K Buy
3,636
+440
+14% +$1.8K ﹤0.01% 538
2025
Q4 		$10.8K Sell
3,196
-191
-6% -$496 ﹤0.01% 567
2025
Q3 		$4.44K Sell
3,387
-584
-15% -$604 ﹤0.01% 612
2025
Q2 		$2.85K Hold
3,971
– – ﹤0.01% 644
2025
Q1 		$5.84K Buy
3,971
+611
+18% +$1.46K ﹤0.01% 615
2024
Q4 		$14.9K Buy
+3,360
New +$13.6K ﹤0.01% 498

Other funds holding IRWD

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

GF Fund Management's IRWD Position: Q1 2026 in Review

GF Fund Management increased its Ironwood Pharmaceuticals (IRWD) stake by 14% in Q1 2026, buying an estimated $1.8K and bringing the position to 3,636 shares worth $12.8K. The position accounts for ﹤0.01% of the portfolio, ranked #538.

GF Fund Management first reported a position in IRWD in Q4 2024 and has held it in 6 quarters since. The position peaked at $14.9K in Q4 2024. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

  • GF Fund Management held 3,636 shares of Ironwood Pharmaceuticals worth $12.8K as of Q1 2026.
  • GF Fund Management bought 440 Ironwood Pharmaceuticals shares in Q1 2026, an estimated $1.8K.
  • Ironwood Pharmaceuticals made up ﹤0.01% of GF Fund Management's portfolio in Q1 2026, its #538 holding.
  • GF Fund Management first reported a position in Ironwood Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • GF Fund Management's Ironwood Pharmaceuticals position peaked at $14.9K in Q4 2024.
  • 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on GF Fund Management's 13F filing for Q1 2026, filed 15 Apr 2026.